ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide

Stock Information for ChromaDex Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ChromaDex Corporation

ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement
ChromaDex Corporation Reports Third Quarter 2024 Financial Results
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
ChromaDex to Participate in the 17th Annual LD Micro Main Event
Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.